RNS Number : 9812A
Itaconix PLC
26 January 2024
 

Itaconix plc

("Itaconix" or the "Company")

Appointment of Nominated Adviser and Sole Broker

 

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonise everyday consumer products, is pleased to announce that it has appointed Canaccord Genuity Limited as its Nominated Advisor and Sole Broker, with immediate effect.

 

In addition to the disclosures made in Paul LeBlanc's appointment announcement on 5 January 2023, the following current directorships are disclosed in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

Company

Supporting Information

Safe Reflections International Holdings LLC

A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix

Protechnic S.A.

A subsidiary of Bemis Associates Inc. directorship held at the time of appointment to Itaconix

 

 

 

Itaconix plc

                          +1 603 775-4400

John R. Shaw / Laura Denner


Belvedere Communications 

+44 (0)20 7653 8702

John West / Llew Angus


Canaccord Genuity - Nominated Adviser and Sole Broker

Adam James / Harry Pardoe

                  +44 (0) 20 7523 8000



 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products.? The Company's current ingredients are enabling and leading new generations of products in cleaning, hygiene, and beauty.£ 

www.itaconix.com?

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APPPPUUPGUPCPUA